Shannon Ritter

1.0k total citations
43 papers, 749 citations indexed

About

Shannon Ritter is a scholar working on Pathology and Forensic Medicine, Ecology and Molecular Biology. According to data from OpenAlex, Shannon Ritter has authored 43 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 10 papers in Ecology and 8 papers in Molecular Biology. Recurrent topics in Shannon Ritter's work include Multiple Sclerosis Research Studies (13 papers), Avian ecology and behavior (9 papers) and Migraine and Headache Studies (8 papers). Shannon Ritter is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Avian ecology and behavior (9 papers) and Migraine and Headache Studies (8 papers). Shannon Ritter collaborates with scholars based in United States, Switzerland and Germany. Shannon Ritter's co-authors include Ludwig Kappos, Philipp von Rosenstiel, Lixin Zhang-Auberson, Gordon Francis, Ernst‐Wilhelm Radue, Davorka Tomic, Paul O’Connor, Reinhard Hohlfeld, Krzysztof Selmaj and Chris H. Polman and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Shannon Ritter

41 papers receiving 729 citations

Peers

Countries citing papers authored by Shannon Ritter

Since Specialization

Citations

This map shows the geographic impact of Shannon Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Ritter more than expected).

Fields of papers citing papers by Shannon Ritter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Ritter. The network helps show where Shannon Ritter may publish in the future.

Co-authorship network of co-authors of Shannon Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Ritter. A scholar is included among the top collaborators of Shannon Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Ritter. Shannon Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Responses of a federally threatened shorebird to trophic downgrading and expansion of domestic cats (Felis catus) 2025 ·Biological Invasions ·(unknown), (unknown), Sarah M. Karpanty, (unknown), (unknown), (unknown), (unknown), Shannon Ritter, Samantha G. Robinson, (unknown), Daniel H. Catlin, James D. Fraser	1
2	The importance of viewshed in nest site selection of a ground-nesting shorebird 2025 ·PLoS ONE ·(unknown), Daniel H. Catlin, Shannon Ritter, (unknown), Samantha G. Robinson, (unknown), (unknown), Sarah M. Karpanty, James D. Fraser	1
3	Red fox home ranges, activity patterns, and resource selection on an Atlantic barrier island 2024 ·Journal of Wildlife Management ·(unknown), Sarah M. Karpanty, Shannon Ritter, Daniel H. Catlin, James D. Fraser	0
4	Early Use of Erenumab vs Nonspecific Oral Migraine Preventives 2024 ·JAMA Neurology ·Patricia Pozo‐Rosich, David Doležil, Koen Paemeleire, Adam Stępień, Philipp Stude, Josefin Snellman, Michał Arkuszewski, Tracy Stites, Shannon Ritter, Cristina López López, Jeff Maca, (unknown), Raquel Gil‐Gouveia	16
5	Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study 2023 ·Pain and Therapy ·R. Agosti, (unknown), Oliver Findling, Peter L. Myers, Jens A. Petersen, Philippe Ryvlin, Peter S. Sándor, (unknown), Chiara Zecca, Josefin Snellman, Shannon Ritter, (unknown), (unknown), Andreas R. Gantenbein	2
6	Long-term Safety and Tolerability of Erenumab In Episodic Migraine: A Pooled Analysis From Two Clinical Trials and Their Extension Phases (P3-2.005) 2022 ·Neurology ·Messoud Ashina, Uwe Reuter, David W. Dodick, Feng Zhang, Shannon Ritter, Tracy Stites, Gabriel Paiva da Silva Lima, Michał Arkuszewski, Peter J. Goadsby	1
7	Factors that affect migratory Western Atlantic red knots (Calidris canutus rufa) and their prey during spring staging on Virginia’s barrier islands 2022 ·PLoS ONE ·(unknown), Sarah M. Karpanty, Jonathan B. Cohen, Daniel H. Catlin, Shannon Ritter, Barry R. Truitt, James D. Fraser	4
8	Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials 2022 ·The Journal of Headache and Pain ·Christian Lampl, (unknown), (unknown), (unknown), (unknown), Zofia Mączyńska, Shannon Ritter, Jan Klatt, Josefin Snellman	14
9	Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study 2021 ·Cephalalgia ·Hans‐Christoph Diener, Messoud Ashina, Shannon Ritter, Gabriel Paiva da Silva Lima, (unknown), Ronald Zielman, Peer Tfelt‐Hansen	5
10	Siponimod Reduces Grey Matter Atrophy in Patients with Secondary Progressive Multiple Sclerosis: Subgroup Analyses from the EXPAND Study (1130) 2020 ·Neurology ·Robert J. Fox, Douglas L. Arnold, Gavin Giovannoni, Bruce Cree, Patrick Vermersch, Amit Bar‐Or, Ralf Gold, Ralph Benedict, Daniela Piani Meier, Sophie Arnould, Shannon Ritter, Frank Dahlke, Goeril Karlsson, Ludwig Kappos	6
11	Long-term Efficacy and Safety of Siponimod in Patients with SPMS: EXPAND Extension Analysis Up to 5 Years (4128) 2020 ·Neurology ·Ludwig Kappos, Gavin Giovannoni, Ralf Gold, Robert J. Fox, Patrick Vermersch, Ralph Benedict, Amit Bar‐Or, Nicolas Rouyrre, Daniela Piani Meier, Shannon Ritter, (unknown), Frank Dahlke, Goeril Karlsson, Bruce Cree	2
12	Magnetization Transfer Imaging in Secondary Progressive Multiple Sclerosis Patients Treated with Siponimod: Results from the Phase 3 EXPAND Study (4037) 2020 ·Neurology ·Douglas L. Arnold, Bruce Cree, Amit Bar‐Or, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Daniela Piani Meier, Sophie Arnould, Shannon Ritter, Goeril Karlsson, Ludwig Kappos, Robert J. Fox	1
13	Effect of Siponimod on Cognition in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Phase 3 EXPAND Study Subgroup Analysis (P3.2-051) 2019 ·Neurology ·Ralph Benedict, Robert J. Fox, Davorka Tomic, Bruce Cree, Patrick Vermersch, Gavin Giovannoni, Amit Bar‐Or, Ralf Gold, Shannon Ritter, Goeril Karlsson, Christian Wolf, Ludwig Kappos	1
14	Multiple Sclerosis Care Optimization Tool (MS-COT): A Clinical application prototype to predict future disease activity (P1.368) 2017 ·Neurology ·(unknown), Daniela Piani Meier, Shannon Ritter, (unknown), Jennie Medin, (unknown), David Ohlssen	1
15	Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials 2017 ·Journal of Neurology ·(unknown), (unknown), Shannon Ritter, Daniela Piani Meier, Merja Soilu‐Hänninen	11
16	Disease activity in the first year predicts longer-term clinical outcomes in the pooled population of the phase III FREEDOMS and FREEDOMS II studies (P7.239) 2015 ·Neurology ·Aaron Boster, Kathleen Hawker, Shannon Ritter, Davorka Tomic, Till Sprenger	5
17	Effect of fingolimod versus interferon-beta1a on no evidence of disease activity or worsening (NEDA-4) in the TRANSFORMS study (P4.001) 2015 ·Neurology ·Xavier Montalbán, Jeffrey A. Cohen, Frederik Barkhof, Bhupendra Khatri, Hans Hartung, Shannon Ritter, Daniela Piani Meier, Davorka Tomic, Ludwig Kappos	5
18	Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study 2015 ·Journal of Neurology Neurosurgery & Psychiatry ·Jeffrey A. Cohen, Bhupendra Khatri, Frederik Barkhof, Giancarlo Comi, Hans-Peter Hartung, Xavier Montalbán, Jean Pelletier, Tracy Stites, Shannon Ritter, Philipp von Rosenstiel, Davorka Tomic, Ludwig Kappos	130
19	Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings 2014 ·Multiple Sclerosis and Related Disorders ·Ludwig Kappos, Jeffrey A. Cohen, William Collins, Ana de Vera, Lixin Zhang-Auberson, Shannon Ritter, Philipp von Rosenstiel, Gordon Francis	95
20	Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders 2008 ·Blood Pressure ·G Nickenig, (unknown), Giuseppe Lembo, (unknown), Thomas Salko, Shannon Ritter, Jack Zhang	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact